STEAP1, STEAP2, and ABCC4 are identified as specific palmitoylated proteins, abundant in large EV (L-EV) and small EV (S-EV) of prostate cancer. Their localization in EVs decreases upon palmitoylation inhibition. Here, STEAP2 is linked to prostate carcinoma.